24th Annual conference of Women’s Cancer Initiative (WCI) of Tata Memorial Hospital discusses how emerging evidence is shaping gynaecological cancer care

The 24th Annual Conference of the Women’s Cancer Initiative–Tata Memorial Hospital (WCI–TMH) in Mumbai discussed the integration of emerging scientific evidence into gynaecological cancer care. The conference, themed “Gynaecological Cancers: Evidence meets Practice,” addressed precision diagnostics, molecular classification, genetic testing, advanced surgical techniques, precision radiotherapy, targeted therapies, and immunotherapy. According to GLOBOCAN 2024 estimates cited at the conference, over 1.5 lakh new cases of cervical, ovarian, and uterine corpus cancers were estimated in India in 2024. The event included international and Indian oncologists exploring multidisciplinary approaches, clinical research, artificial intelligence applications in oncology, and specialised pre-conference workshops.